UBIVAC
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the Robert W. Franz Cancer Research Center within the Earle A. Chiles Research Institute, at Providence Portland Medical Center, UbiVac continues to build upon the groundbreaking research being developed in the region.
UBIVAC
Social Links:
Industry:
Biotechnology Health Care Wellness
Founded:
2005-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.ubivac.com
Total Employee:
1+
Status:
Active
Total Funding:
2.2 M USD
Technology used in webpage:
Viewport Meta Euro SPF Content Delivery Network IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Pound Sterling Microsoft Azure DNS
Similar Organizations
Access VC
Access VC invests in founders who fight for access to better health, hygiene & nutrition.
Aravax
Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
NAVICAN
NAVICAN offers a comprehensive end-to-end solution to help both oncologists and patients.
NeuPharma
NeuPharma is a biotech company dedicated to research and development of innovative medicines.
Proteas Bioanalytics
Proteas Bioanalytics is a biotechnology platform intended to determine any disease from a single drop of blood.
PureForm Global
PureForm Global is a biotechnology company that specializes in the research, development, and commercialization of CBD and cannabinoids.
Tanox, Inc.
Tanox, Inc. is a a biotechnology company, engages in the discovery and development of therapeutic monoclonal antibodies.
Welichem Biotech
Welichem Biotech is a development stage biotechnology company, engages in the discovery and development of therapeutic drugs.
Current Employees Featured
Founder
Official Site Inspections
http://www.ubivac.com
- Host name: 104.21.88.166
- IP address: 104.21.88.166
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "UbiVac"
UbiVac - Crunchbase Company Profile & Funding
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, …See details»
UbiVac
UbiVac has unique and disruptive immune educating and activating vaccine technology. UbiVac’s lead agent, DPV-001, contains the newly discovered cancer’s “Dark Matter”, non-mutated shared cancer neoantigens derived from …See details»
Executive Leadership - UbiVac
Executive Leadership . © 2020 UbiVac | All rights reserved.See details»
UbiVac - LinkedIn
UbiVac is a clinical stage biotech engaged in research and development, and manufacture, of therapeutic immune activators, vaccines and cellular immunotherapies to combat cancer.See details»
UbiVac - The Org
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the …See details»
UbiVac - Products, Competitors, Financials, Employees, …
UbiVac is a clinical-stage immunotherapy and cancer target discovery company operating in the biotechnology sector. It focuses on the research, development, and manufacture of …See details»
UbiVac 2025 Company Profile: Valuation, Funding & Investors
UbiVac General Information Description. Operator of a biotech company designed to develop therapeutic immune activators and vaccines to combat cancer. The company offers a patented …See details»
UbiVac Company Profile - Office Locations, Competitors, Revenue …
UbiVac is a biotechnology company developing and commercializing immunotherapy products that induce anti-cancer immunity. It offers DRibble immunotherapy, the technology that …See details»
Ubivac, Inc. Company Profile | Portland, OR - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ubivac, Inc. of Portland, OR. Get the latest business insights from Dun & Bradstreet.See details»
UBIVAC, LLC - VentureRadar
UbiVac is a biotechnology company focusing on discovering, licensing, improving, and commercializing immunotherapy products that safely generate and augment the immune …See details»
UbiVac - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 14, 2022: Seed Round - …See details»
UbiVac - Contacts, Employees, Board Members, Advisors & Alumni …
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. ... Pricing. Log In. Log In. Experience the new …See details»
UbiVac: Contact Details and Business Profile - RocketReach
UbiVac is a clinical stage biotech engaged in research and development, and manufacture, of therapeutic immune activators, vaccines and cellular immunotherapies to combat cancer. …See details»
Pipeline — UbiVac
Pipeline. UbiVac and collaborators are in various stages of research and clinical trials with a pipeline of immunotherapeutic products that include cancer vaccine technologies and cellular …See details»
UbiVac - Biotech Careers
Since 2005 the company has been engaged in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases. UbiVac’s …See details»
UbiVac, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore UbiVac, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 21 news, and 2 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, …See details»
UbiVac - Overview, News & Similar companies | ZoomInfo.com
Who is UbiVac. UbiVac is a clinical stage Immuno-Oncology company engaged in development of immunotherapies to combat cancer. UbiVac's DPV-001 is currently in a p hase II randomized …See details»
Bernard A. Fox: UbiVac is excited to have the world’s 1st …
Jan 27, 2025 UbiVac is excited to have the world’s 1st immunotherapy that targets cancer’s Dark Matter as well as >300 TAAs, and wraps it all up in an off-the-shelf microparticle packed with …See details»
Technologies - UbiVac
UbiVac’s DRibble immunotherapy is a first in class technology that combines more than 100 cancer targets, including at least 13 NCI prioritized cancer antigens, together with five immune …See details»
Introducing UniFi Organizations – Ubiquiti Help Center
To get started, see Creating a UniFi Organization for a complete setup guide. Key Features Centralized Identity & Access Management (IAM) Unified list of users and admins across all …See details»